# Mark Boguniewicz

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/mark-boguniewicz/

## Facts

| Field | Value |
| --- | --- |
| Citations | 27,303 |
| Field | Dermatology and Skin Diseases |
| h-index | 82 |
| i10-index | 173 |
| OpenAlex ID | https://openalex.org/A5055081212 |
| ORCID iD | 0000-0002-1015-4439 |
| Works | 380 |

## Researcher papers

Showing 12 of 19.

- [Endogenous Antimicrobial Peptides and Skin Infections in Atopic Dermatitis](https://scholariq.org/papers/endogenous-antimicrobial-peptides-and-skin-infections-in-atopic-dermatitis/)
- [New insights into atopic dermatitis](https://scholariq.org/papers/new-insights-into-atopic-dermatitis/)
- [Cytokine modulation of atopic dermatitis filaggrin skin expression](https://scholariq.org/papers/cytokine-modulation-of-atopic-dermatitis-filaggrin-skin-expression/)
- [Atopic dermatitis: a disease of altered skin barrier and immune dysregulation](https://scholariq.org/papers/atopic-dermatitis-a-disease-of-altered-skin-barrier-and-immune-dysregulation/)
- [Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis.](https://scholariq.org/papers/differential-in-situ-cytokine-gene-expression-in-acute-versus-chronic-atopic/)
- [Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report](https://scholariq.org/papers/diagnosis-and-treatment-of-atopic-dermatitis-in-children-and-adults-european/)
- [Tight junction defects in patients with atopic dermatitis](https://scholariq.org/papers/tight-junction-defects-in-patients-with-atopic-dermatitis/)
- [Cytokine Milieu of Atopic Dermatitis, as Compared to Psoriasis, Skin Prevents Induction of Innate Immune Response Genes](https://scholariq.org/papers/cytokine-milieu-of-atopic-dermatitis-as-compared-to-psoriasis-skin-prevents/)
- [Patient burden and quality of life in atopic dermatitis in US adults](https://scholariq.org/papers/patient-burden-and-quality-of-life-in-atopic-dermatitis-in-us-adults/)
- [Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults](https://scholariq.org/papers/efficacy-and-safety-of-crisaborole-ointment-a-novel-nonsteroidal/)
- [Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis](https://scholariq.org/papers/efficacy-and-safety-of-dupilumab-in-adolescents-with-uncontrolled-moderate-to/)
- [Cytokine modulation of atopic dermatitis filaggrin skin expression](https://scholariq.org/papers/cytokine-modulation-of-atopic-dermatitis-filaggrin-skin-expression-2/)

## Researcher topics

- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)
- [Allergic Rhinitis and Sensitization](https://scholariq.org/topics/allergic-rhinitis-and-sensitization/)
- [Asthma and respiratory diseases](https://scholariq.org/topics/asthma-and-respiratory-diseases/)
- [Food Allergy and Anaphylaxis Research](https://scholariq.org/topics/food-allergy-and-anaphylaxis-research/)
- [Urticaria and Related Conditions](https://scholariq.org/topics/urticaria-and-related-conditions/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.